- Home
- RCON vs CNTX Comparison
RCON vs CNTX Comparison
Compare RCON & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- CNTX
- Stock Information
- Founded
- RCON 2007
- CNTX 2015
- Country
- RCON China
- CNTX United States
- Employees
- RCON N/A
- CNTX N/A
- Industry
- RCON Oilfield Services/Equipment
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- CNTX Health Care
- Exchange
- RCON Nasdaq
- CNTX Nasdaq
- Market Cap
- RCON 86.1M
- CNTX 78.0M
- IPO Year
- RCON 2009
- CNTX 2021
- Fundamental
- Price
- RCON $2.58
- CNTX $0.72
- Analyst Decision
- RCON
- CNTX Strong Buy
- Analyst Count
- RCON 0
- CNTX 5
- Target Price
- RCON N/A
- CNTX $5.25
- AVG Volume (30 Days)
- RCON 2.6M
- CNTX 198.0K
- Earning Date
- RCON 08-19-2025
- CNTX 08-06-2025
- Dividend Yield
- RCON N/A
- CNTX N/A
- EPS Growth
- RCON N/A
- CNTX N/A
- EPS
- RCON N/A
- CNTX N/A
- Revenue
- RCON $8,996,572.00
- CNTX N/A
- Revenue This Year
- RCON N/A
- CNTX N/A
- Revenue Next Year
- RCON $12.17
- CNTX N/A
- P/E Ratio
- RCON N/A
- CNTX N/A
- Revenue Growth
- RCON N/A
- CNTX N/A
- 52 Week Low
- RCON $1.40
- CNTX $0.49
- 52 Week High
- RCON $7.16
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- RCON 48.48
- CNTX 46.79
- Support Level
- RCON $2.50
- CNTX $0.68
- Resistance Level
- RCON $4.50
- CNTX $0.84
- Average True Range (ATR)
- RCON 0.99
- CNTX 0.05
- MACD
- RCON -0.04
- CNTX -0.02
- Stochastic Oscillator
- RCON 13.75
- CNTX 21.85
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.